Cromoz announces CNT-based targeted cancer theranostic to enter human trials in early 2010
December 01, 2009 | Analyst Insight
Cromoz, a bionanotech startup based in North Carolina, recently announced that it would begin animal testing and, if all goes well, human testing of its carbon nanotubes (CNTs) in cancer therapies;...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.